Introducing semi-permanent PMMA filler in Korea

At present, semi-permanent fillers containing PMMA are widely used in plastic surgery hospitals in Korea. Artefill, which is imported and supplied by AESTURA, a family of AMOREPACIFIC Group, is a product that uses PMMA. In 1996, a German plastic surgery doctor developed a semi-permanent filler for cosmetic purposes, and Dr. Lee first brought it to Korea.
Cleviel is a product developed by AETURA that, unlike semi-permanent fillers, is a short-term filler. Dr. Lee rates the efficacy of Cleviel and Artefill highly, and he recommends Cleviel to other plastic surgery hospitals, as he was injected with it himself.

Dr. Lee urges all members of AMOREPACIFIC to know AESTURA, a supplier of high-quality semi-permanent filler.

Although Artefill, imported and supplied by AESTURA, a family of AMOREPACIFIC Group, is a safe and natural product that creates a self-collagen building response and is the only filler product to be approved by the US FDA, its market share remains minimal in Korea due to Artecoll being imported from Europe. Developed by the same person, Artecoll is wrongly assumed in Korea to be the only product to meet the strictest US FDA requirements, even though it in fact only acquired European certification. This is because of the way it has been marketed this way and, as a result, come to dominate the market for a long time. The fact remains though, that it simply isn't true.
Dr. Lee specifically delivered his message to AMOREPACIFIC Group, the best beauty company in Korea and the best brand in China. "All members of AESTURA, as well as AMOREPACIFIC Group, should be acutely aware that really good filler products are currently supplied by AESTURA," he noted, when explaining the reason and goal of his new column for News Square. In his column, Dr. Lee will introduce interesting knowledge about cosmetic plastic surgery that is rich in specialist insight. Here's hoping you enjoy his articles.